Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 12-2018 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 0 | 0 | 2,729 |
| TOTAL | $N/A | $0 | $0 | $0 | $2,864 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 919 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $919 |
| Total Assets | $N/A | $0 | $0 | $0 | $3,783 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 1,246 |
| Accrued Expenses | N/A | 0 | 0 | 0 | 1,192 |
| TOTAL | $N/A | $0 | $0 | $0 | $2,438 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | -31,045 | -27,057 | 0 | 2,632 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $2,632 |
| Total Liabilities | $N/A | $0 | $0 | $0 | $5,070 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 0 | 0 | 0 | 40 |
| Retained earnings | N/A | 0 | 0 | 0 | -329,252 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -380 |
| TOTAL | $N/A | $0 | $0 | $0 | $-1,287 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $3,783 |